Grantham, Mayo, Van Otterloo & Co (GMO)
HRMY icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Harmony Biosciences HRMY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$397K Sell
10,891
-291
-3% -$9.18K ﹤0.01% 584
2026
Q1 		$313K Buy
11,182
+5,811
+108% +$191K ﹤0.01% 590
2025
Q4 		$201K Buy
+5,371
New +$177K ﹤0.01% 635

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s HRMY Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Harmony Biosciences (HRMY) stake by 2.6% in Q2 2026, selling an estimated $9.18K and leaving 10,891 shares worth $397K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in HRMY in Q4 2025 and has held it in 3 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 10,891 shares of Harmony Biosciences worth $397K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 291 Harmony Biosciences shares in Q2 2026, an estimated $9.18K.
  • Harmony Biosciences made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #584 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Harmony Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.